Market Tracker

08/25 7:24am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

21.86
Delayed Data
As of Aug 24
 -0.89 / -3.91%
Today’s Change
9.51
Today|||52-Week Range
24.00
+62.65%
Year-to-Date

Today’s Trading

Previous close22.75
Today’s open22.81
Day’s range21.73 - 23.18
Volume472,192
Average volume (3 months)542,853
Market cap$1.1B
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+150.00%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+18.34%
P/E ratio43.7
Price/Sales4.76
Price/Book9.38

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.36+1.80%
EBSEmergent BioSolution...-0.57-2.06%
MGNXMacroGenics Inc-2.19-6.97%
INSYINSYS Therapeutics I...-0.67-4.09%
Data as of 08/24/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$0.18
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts